Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.
暂无分享,去创建一个
W. Ryu | Seung-Hoon Lee | B. Yoon | Chulho Kim | B. Kim | C. Kim
[1] A. Larsson,et al. Pentraxin 3 Increase is Much Less Pronounced Than C-Reactive Protein Increase After Surgical Procedures , 2011, Inflammation.
[2] I. D. de Boer,et al. Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] W. Ryu,et al. Effects of low serum triglyceride on stroke mortality: a prospective follow-up study. , 2010, Atherosclerosis.
[4] Sung-il Cho,et al. Increases in body mass index over a 7-year period and risk of cause-specific mortality in Korean men. , 2010, International journal of epidemiology.
[5] C. Garlanda,et al. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. , 2010, Trends in cardiovascular medicine.
[6] A. Gass,et al. Copeptin: A novel, independent prognostic marker in patients with ischemic stroke , 2009, Annals of neurology.
[7] Kwang-Soo Lee,et al. Relationship between High-Sensitivity C-Reactive Protein and Clinical Functional Outcome after Acute Ischemic Stroke in a Korean Population , 2009, Cerebrovascular Diseases.
[8] L. Kuller,et al. Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause Death: The Cardiovascular Health Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[9] K. Node,et al. Prognostic value of pentraxin 3 in patients with chronic heart failure. , 2008, International journal of cardiology.
[10] J. Carrero,et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[11] I. Kubota,et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. , 2007, American heart journal.
[12] T. Kodama,et al. Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[13] F. Aichner,et al. Admission C-reactive protein as a predictor for stroke outcome among candidates for thrombolysis: decision adjourned. , 2006, Stroke.
[14] Sun Ha Jee,et al. Body-mass index and mortality in Korean men and women. , 2006, The New England journal of medicine.
[15] Gianni Tognoni,et al. Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction , 2004, Circulation.
[16] A. Mantovani,et al. Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. , 2004, Atherosclerosis.
[17] V. Feigin,et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.
[18] C. Garlanda,et al. Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[19] G Olivetti,et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. , 2000, Circulation.
[20] Francesco Tedesco,et al. Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 , 1997, The Journal of Biological Chemistry.
[21] J. Garthwaite,et al. Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke , 1997, Annals of clinical biochemistry.
[22] Barbara Bottazzi,et al. Pentraxins in Innate Immunity: From C-Reactive Protein to the Long Pentraxin PTX3 , 2007, Journal of Clinical Immunology.
[23] C. Garlanda,et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. , 2005, Annual review of immunology.
[24] M. Di Napoli,et al. C-reactive protein and outcome after first-ever ischemic stroke. , 2000, Stroke.